"Biden Administration Faces Congressional Scrutiny Over Marijuana Rescheduling Plans"
Congressman Earl Blumenauer is seeking clarification from the U.S. Department of Health and Human Services (HHS) regarding its reported request for a legal opinion from the Justice Department on the potential implications of marijuana rescheduling. The Biden administration's review of marijuana scheduling has sparked tension, with opponents of reform urging the Drug Enforcement Administration (DEA) to keep cannabis in Schedule I due to international treaty concerns. Legal experts and lawmakers have disputed this argument, emphasizing that rescheduling to Schedule III would better align with international obligations while promoting public health and safety. Blumenauer and Rep. Andy Harris have expressed frustration over the lack of progress in implementing cannabis research legislation.
